Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Jul 27, 2021

Why Valuentum Buying Index Ratings Matter
Let's take a look at the results of a case study of an institutional money manager's application of the Valuentum Buying Index rating system.

Jul 23, 2021

Shares of Best Idea Domino’s Pizza Jump Higher!
Image Shown: In the wake of Domino’s Pizza Inc’s stellar fiscal second quarter earnings report published on July 22, shares of DPZ surged higher. We include Domino’s Pizza as an idea in the Best Ideas Newsletter portfolio and continue to be huge fans of the name. On July 22, Domino’s Pizza reported second quarter earnings for fiscal 2021 (period ended June 20, 2021) that smashed past consensus top- and bottom-line estimates with its US same-store sales growing by 3.5% and its international same-store sales increasing by 13.9%. The company noted that last fiscal quarter represented its 41st consecutive quarter of same-store sales growth in the US as its digital and delivery investments over the past decade have really paid off. Domino’s Pizza announced that it had authorized a new $1.0 billion share buyback program after the end of the fiscal second quarter after recently completing its previous $1.0 billion share repurchase program via an accelerated share repurchase (‘ASR’) agreement.

Jul 23, 2021

Dividend Increases/Decreases for the Week July 23
Let's take a look at companies that raised/lowered their dividend this week.

Jul 22, 2021

Johnson & Johnson Beats Estimates, Raises Guidance Once Again
Image Source: Johnson & Johnson – Second Quarter of 2021 IR Earnings Presentation. On July 21, Johnson & Johnson reported second-quarter 2021 earnings that beat both consensus top- and bottom-line estimates. The company (once again) boosted its full-year guidance in conjunction with its latest earnings update as Johnson & Johnson’s business is steadily rebounding from the worst of the coronavirus (‘COVID-19’) pandemic, with an eye towards the ongoing recovery in the sales of its medical devices and related offerings. We include shares of JNJ as an idea in both the Best Ideas Newsletter and Dividend Growth Newsletter portfolios. Its latest earnings report and guidance boost reinforced our favorable view towards the name. Shares of JNJ yield ~2.5% as of this writing, and the top end of our recently updated fair value estimate range sits at $206 per share of Johnson & Johnson, well above where shares are trading at as of this writing.

Jul 22, 2021

Best Idea Chipotle Rockets Higher!
Image Shown: We include Chipotle Mexican Grill Inc an as idea in the Best Ideas Newsletter portfolio. On July 21, shares of CMG surged higher after the firm reported a stellar earnings report after the market close on July 20. In our April 2021 article covering the company, we highlighted how Chipotle’s management team sees room for the firm to more than double its restaurant unit count in the coming years. Chipotle’s growth runway is immense. The company’s second-quarter earnings report was stellar, and the market continues to warm up to Chipotle’s promising long-term growth story. We are big fans of Chipotle and expect that the firm’s free cash flows will continue to grow at a steady clip over the coming years.

Jul 21, 2021

Philip Morris’ Transformation Continues
Image Shown: Philip Morris International Inc’s IQOS offering, a heated tobacco unit product (also classified as a “reduced risk product” by the company) that seeks to replicate the experience of traditional cigarettes for smokers in a bid to get those users to switch over to an offering the company views as relatively “safer,” has continued to post solid user base growth of late. We are big fans of Philip Morris and its ongoing transformation and include shares of PM as an idea in the High Yield Dividend Newsletter portfolio. Image Source: Philip Morris International Inc – Second Quarter of 2021 IR Earnings Presentation. On July 20, the company behind the Marlboro cigarette brand (excluding sales of the cigarette brand in the US) and the smokeless IQOS nicotine offering Philip Morris International reported second quarter 2021 earnings. The company missed consensus top-line estimates but beat consensus bottom-line estimates and boosted its full-year guidance for 2021 in conjunction with the report. Now Philip Morris expects to generate (the following are non-GAAP metrics) organic net revenue growth of 6%-7% (up from 5%-7% previously) and adjusted diluted EPS growth of 12%-14% (up from 11%-13% previously) on an annual basis in 2021 as its business steadily recovers from the worst of the coronavirus (‘COVID-19’) pandemic.

Jul 21, 2021

Robotic-Assisted Surgery Idea Intuitive Surgical Rebounds Nicely in Second Quarter
Image shown: Intuitive Surgical benefits from a razor-razor blade business model and a large installed base. The more systems it places, the more instruments and accessories are sold. We expect clinical applications for robotic-assisted surgeries to continue to increase. Image source: Intuitive Surgical's second-quarter earnings press release. We’re huge fans of Intuitive Surgical’s razor-razor blade business model (systems/instruments and accessories), and the company remains one of the most innovative in our coverage. We expect clinical applications for robotic-assisted surgeries to increase over time, and Intuitive Surgical is at the sweet spot of this care. Free cash flow generation is consistently robust at the firm, and the company’s balance sheet is very net cash rich. Intuitive is worth a look at the right price, in our view.

Jul 19, 2021

Bank Earnings Solid During Second Quarter 2021
Image Source: Bank of America Corporation – Second Quarter of 2021 IR Earnings Presentation. After reviewing the second quarter earnings reports of several major US banking institutions, the domestic economy continues to stage an impressive though uneven economic recovery. Net credit write-offs have been trending aggressively lower of late, a welcome sign. Banks are taking advantage of their improving financial outlook and have been aggressively rewarding shareholders via dividend increases and/or large share buyback programs.

Jul 19, 2021

Conagra Brands Facing Major Inflationary Headwinds
Image Shown: Conagra Brands Inc recently reduced its full-year guidance for fiscal 2022 in the face of major inflationary headwinds. Image Source: Conagra Brands Inc – Fourth Quarter of Fiscal 2021 IR Earnings Presentation. On July 13, the company behind the Slim Jim, Duncan Hines, Gardein brands (among other), Conagra Brands reported fourth quarter earnings for fiscal 2021 (period ended May 30, 2021) that beat both consensus top- and bottom-line estimates. However, its guidance for fiscal 2022 came in a bit light in the face of major inflationary headwinds which saw shares sell off initially after the report was published. Please note that its fiscal 2020 was a 53 week reporting period while its fiscal 2021 was a 52 week reporting period, making GAAP year-over-year comparisons noisy, and that is before taking the coronavirus (‘COVID-19’) pandemic into account.

Jul 16, 2021

Dividend Growth Idea UnitedHealth Group Surges Towards All-Time Highs After Stellar Earnings Update, Guidance Boost
Image Shown: Shares of UnitedHealth Group Inc, an idea in the Dividend Growth Newsletter portfolio, are trading near their all-time highs as of this writing after the firm reported a stellar second quarter 2021 earnings report. In conjunction with its latest earnings report, UnitedHealth Group once again raised its full-year adjusted EPS guidance for 2021. We continue to be huge fans of the name. We are enormous fans of UnitedHealth Group, and the healthcare giant has not disappointed since we added shares of UNH as an idea to the Dividend Growth Newsletter portfolio back on November 27, 2020. Shares of UNH are up 26% from November 27 to July 15, outperforming the 20% gain seen at the S&P 500 during this period before considering dividend considerations (which would not change this picture much). The company’s balance sheet is pristine, its free cash flow generating abilities are simply stellar, and its growth outlook is incredibly bright. Recent guidance increases highlight management’s confidence that UnitedHealth Group is steadily recovering from the COVID-19 pandemic, keeping in mind that the resumption of elective surgeries and other heath service activities during the second half of this year will create temporary headwinds for the firm. Heading into 2022, UnitedHealth Group sees its various businesses having ample momentum, and the company’s growth outlook over the long haul is incredibly promising. We like UnitedHealth Group as an idea in the Dividend Growth Newsletter portfolio.